Transhepatic artery chemoembolization for liver metastases of primary retroperitoneal endodermal sinus tumor -: A case report

被引:0
作者
Chen, CL
Wang, PH
Ng, HT
Yuan, CC
机构
[1] Vet Gen Hosp, Dept Obstet & Gynecol, Taipei 11217, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
关键词
chemoembolization; therapeutic; endodermal sinus tumor; liver neoplasms; metastasis; retroperitoneal neoplasms;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Primary retroperitoneal endodermal sinus tumors (EST) are extremely rare and highly Malignant. Hepatic metastases I from EST are often very difficult to manage and carry a dismal prognosis. Transhepatic artery chemoembolization has been widely applied in primary unresectable hepatoma and had been reported to have antitumor activity for some metastatic tumors. We report a case in which transhepatic artery chemoembolization runs employed to control hepatic metastases from EST. CASE: A 35-year-old woman presented to our service with primary retroperitoneal EST associated with multiple hepatic metastases. The patient underwent aggressive debulking surgery followed by a combination chemotherapy regimen of cisplatin, vinblastine and bleomycin. Transhepatic artery chemoembolization with adriamycin, lipoidol and gelfoam runs subsequently employed to treat hepatic metastases. CONCLUSION: The combination of transhepatic artery chemoembolization and systemic chemotherapy after surgical resection of primary retroperitoneal EST was effective in controlling the hepatic disease in this case.
引用
收藏
页码:559 / 562
页数:4
相关论文
共 20 条
[1]  
Berek Jonathan S., 1996, P1155
[2]  
CANGIR A, 1978, CANCER, V42, P1234, DOI 10.1002/1097-0142(197809)42:3<1234::AID-CNCR2820420331>3.0.CO
[3]  
2-#
[4]  
COZZI PJ, 1995, REG CANC TREAT, V8, P156
[5]  
FRIEDMAN NB, 1951, CANCER, V4, P265, DOI 10.1002/1097-0142(195103)4:2<265::AID-CNCR2820040211>3.0.CO
[6]  
2-X
[7]  
KURMAN RJ, 1976, CANCER, V38, P2404, DOI 10.1002/1097-0142(197612)38:6<2404::AID-CNCR2820380629>3.0.CO
[8]  
2-3
[9]  
MAVLIGIT GM, 1991, CANCER, V68, P321, DOI 10.1002/1097-0142(19910715)68:2<321::AID-CNCR2820680219>3.0.CO
[10]  
2-B